Xilio Therapeutics, Inc. (XLO) Net income 2020–2025
Xilio Therapeutics, Inc. (XLO) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$35.0MFY2025 · since FY2020: -$55.2M → -$35.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$35.0M | +39.8% |
| FY2024 | -$58.2M | +23.8% |
| FY2023 | -$76.4M | +13.4% |
| FY2022 | -$88.2M | -16.4% |
| FY2021 | -$75.8M | -37.3% |
| FY2020 | -$55.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice